RCM vs. TMX, MANT, PINC, FC, LH, DGX, DVA, CHE, CRVL, and AMED
Should you be buying R1 RCM stock or one of its competitors? The main competitors of R1 RCM include Terminix Global (TMX), ManTech International (MANT), Premier (PINC), Franklin Covey (FC), Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), CorVel (CRVL), and Amedisys (AMED).
R1 RCM (NASDAQ:RCM) and Terminix Global (NYSE:TMX) are both mid-cap business services companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability, community ranking, media sentiment and analyst recommendations.
Terminix Global has a net margin of 3.15% compared to R1 RCM's net margin of -1.39%. Terminix Global's return on equity of 4.95% beat R1 RCM's return on equity.
In the previous week, R1 RCM had 4 more articles in the media than Terminix Global. MarketBeat recorded 4 mentions for R1 RCM and 0 mentions for Terminix Global. R1 RCM's average media sentiment score of 1.60 beat Terminix Global's score of 0.00 indicating that R1 RCM is being referred to more favorably in the media.
R1 RCM presently has a consensus price target of $16.31, indicating a potential upside of 26.81%. Given R1 RCM's higher probable upside, equities analysts plainly believe R1 RCM is more favorable than Terminix Global.
R1 RCM received 216 more outperform votes than Terminix Global when rated by MarketBeat users. However, 61.32% of users gave Terminix Global an outperform vote while only 57.94% of users gave R1 RCM an outperform vote.
61.1% of R1 RCM shares are held by institutional investors. Comparatively, 92.2% of Terminix Global shares are held by institutional investors. 36.8% of R1 RCM shares are held by company insiders. Comparatively, 2.3% of Terminix Global shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Terminix Global has lower revenue, but higher earnings than R1 RCM. R1 RCM is trading at a lower price-to-earnings ratio than Terminix Global, indicating that it is currently the more affordable of the two stocks.
R1 RCM has a beta of 0.78, meaning that its stock price is 22% less volatile than the S&P 500. Comparatively, Terminix Global has a beta of 0.78, meaning that its stock price is 22% less volatile than the S&P 500.
Summary
R1 RCM and Terminix Global tied by winning 8 of the 16 factors compared between the two stocks.
Get R1 RCM News Delivered to You Automatically
Sign up to receive the latest news and ratings for RCM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding RCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
